Shock Wave Therapy + Local Vibration Beneficial for Chronic Plantar Fasciitis
30 Jan 2024
Clinical Result
TUESDAY, Jan. 30, 2024 -- For patients with chronic plantar fasciitis, extracorporeal shock wave therapy combined with local vibration (ESWT-LV) is effective compared with ESWT alone, according to a study recently published in the Journal of Rehabilitation Medicine.
HyoJeong On and JongEun Yim, D.Sc., from the Graduate School of Sahmyook University in Seoul, South Korea, conducted a trial involving 34 patients (mean age, 37.5 years) with chronic plantar fasciitis who were randomly assigned to treatment with ESWT-LV or with ESWT alone. In each group, participants underwent two treatment sessions weekly for five weeks.
The researchers found that in both groups, there were significant improvements in the thickness of the plantar fascia, numerical rating scale for pain, and Foot Function Index values. Significantly greater decreases were seen in the thickness of the plantar fascia and pain in the ESWT-LV versus the ESWT-alone group. Foot Function Index values did not differ significantly between the groups.
"Based on these results, LV can be considered an effective adjunct to ESWT for plantar fasciitis," the authors write. "Further studies are necessary to determine the best parameters for LV combined with ESWT treatment in muscular skeletal disorders, in order to establish a treatment protocol."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.